Bioelectronics Corp (BIEL)

[imrichbeotch]

BioElectronics Investor Update – Thursday, February 16, 2012


Recent Updates – BioElectronics Corporation


European Health Care

BioElectronics Andrew Whelan and Patrick O’Leary, President of Greenwood Group, is attending the prestigious European Health Care, Vitamin, Diet & Nutrition Show in Monte Carlo on Feb. 21 -23. The event allows manufacturers of OTC products, such as BIEL, to present their products and programs to Eastern and Western European retailers and distributors from many nations representing numerous different potential sellers of these products. “Readers of our bi-monthly newsletter will note the trend. We attended a similar important conference recently representing a number of Arab nations and we also spoken in these updates about our efforts to garner shelf space and sales in Canada. We will soon be announcing that Shanghai Suokang Medical Implants Co. Ltd. will be distributing BIEL products in China, the world’s most populous nation. That very successful company has wide-ranging resources, including the ability to do extensive clinical trials. We are following through on our stated goal to make our products known and sold worldwide rather than simply waiting for approvals in the U.S.,” Mr. Whelan explained. “These kinds of conferences are vital in allowing us to present our products to many retailers in just a few days.”


Juno Pharmaceuticals

BioElectronics signed a Distribution Agreement with Juno Pharmaceuticals, headquartered in Hyderabad, India. Juno Pharmaceuticals (http://www.junopharm.com) is relatively new entity funded and supported by experienced Canadian and Indian private equity fund managers focused on global opportunities in sourcing, licensing and acquisition of pharmaceutical and medical devices. “I believe our purpose is clear. Ours will be an international company with sales throughout the globe by the very best distributors and retailers we can find,” Mr. Whelan stressed.